No Data
Otsuka Holdings Expands Into North American IV Market
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc., a Subsidiary of Otsuka Holdings Co. Ltd., Announce Creation of a Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America
List of cloud breakout stocks (Part 1) [Ichimoku Kinko Hyo Cloud Breakout Stock List]
○ Cloud Break Stocks Market List Code Company Name Closing Price Leading Span A Leading Span B Tokyo Stock Exchange Main Board <1941> Chuden 3385 3298.75 3087 <1969> Takasago Netsu 52255198.755222.5 <2130> Members 946913.5832.5 <3064> MRO 25022409.52276.5 <3415> Tokyo Base 254246253 <3
Canon Inc-spons adr, 3Q operating profit increased by 14.4% to 296.6 billion yen.
Canon Inc-Spons ADR <7751> announced its third quarter financial results for the fiscal year ending December 2024, with revenue increasing by 7.3% year-on-year to 3 trillion 236.1 billion 11 million yen, operating profit increasing by 14.4% to 296.6 billion 38 million yen. The gross profit margin increased by 0.8 points from the same period last year to 47.8%, due to cost reductions and favorable product mix, with gross profit also increasing by 7.1% year-on-year to 516.4 billion yen. [Positive evaluation] Takeda Pharmaceuticals Mid-Term <4502> | <7735> S
Summary of financial results for the third quarter of the fiscal year ending December 2024.
Otsuka Shokai Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo, President and CEO: Yuji Otsuka) will announce the overview of the financial results for the third quarter of the fiscal year ending December 2024. Regarding the financial results of the third quarter of the fiscal year ending December 2024 (January 1, 2024, to September 30, 2024), during this cumulative period of the third quarter, while there were some weaknesses due to the continued high resource prices and yen depreciation leading to high prices, improvements in the employment and income environment led to a recovery in personal consumption and solid corporate performance.
Otsuka: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12
No Data
No Data